Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV open-label multicenter study of Liqinuanwei granule in chronic non-atrophic gastritis
ChiCTR-OPC-15006188Phase 4Recruiting
- Sponsor
- Huiren Group
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Liqi Nuanwei Granules in chronic non-atrophic gastritis, sponsored by Huiren Group. Primary endpoints: Main symptom scores, Pain VAS score and 2 more. Started Feb 2015; status: recruiting.
02
Drugs
Liqi Nuanwei Granules
03
Conditions
chronic non-atrophic gastritis
Beyond the preview
Go deeper on ChiCTR-OPC-15006188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006188.